Related Experiment Videos
Expression profiles of BRCA1 splice variants in asynchronous and in G1/S synchronized tumor cell lines
1National Institute of Oncology, Department of Molecular Biology, Rath Gy.u.7-9, Budapest, Pf. 21, H-1525, Hungary.
Abstract:
Disrupting the function of the BRCA1 gene by mechanisms other than germline mutations is suspected to occur in cases of sporadic breast/ovarian cancers. Using ribonuclease protection assay and multiplex RT-PCR, we examined the change of the total BRCA1 mRNA pool and the expression profile of four predominant BRCA1 splice variants in asynchronous and in G1/S synchronized tumor cell populations compared to normal breast cells. Experiments were carried out on MCF-7 and MDA-MB-231 breast cancer, OVCAR-5 ovarian cancer, and K562 leukemia cell lines. The ratio of the full length, the delta(11q), the delta(9,10), and the delta(9,10,11q) BRCA1 isoforms showed different expression patterns in the examined breast and ovarian tumor cell lines as compared to the leukemia cell line. This observation raises the possibility that the dysregulation of alternative splicing of the BRCA1 gene could be involved in tumor formation in the breast and the ovary, even in the absence of germline mutations.
Insights
Altered splicing of the BRCA1 gene, not caused by inherited mutations, may contribute to sporadic breast and ovarian cancers. This study reveals distinct BRCA1 splice variant expression patterns in tumor cells.
Area of Science:
- Molecular biology
- Genetics
- Oncology
Background:
- Sporadic breast and ovarian cancers may involve BRCA1 gene disruptions beyond germline mutations.
- Understanding alternative splicing of BRCA1 is crucial for non-hereditary cancer research.
Purpose of the Study:
- To investigate alterations in the BRCA1 mRNA pool and splice variant expression in cancer cell lines.
- To compare BRCA1 expression profiles in breast, ovarian, and leukemia cancer cells versus normal breast cells.
Main Methods:
- Ribonuclease protection assay and multiplex reverse transcription-polymerase chain reaction (RT-PCR) were employed.
- Analysis focused on BRCA1 mRNA levels and four major splice variants: full-length, delta(11q), delta(9,10), and delta(9,10,11q).
- Experiments utilized MCF-7, MDA-MB-231 (breast), OVCAR-5 (ovarian), and K562 (leukemia) cell lines, including synchronized cell populations.
Main Results:
- Distinct expression patterns of BRCA1 splice variants were observed in breast and ovarian tumor cell lines compared to the leukemia cell line.
- Differences in the ratios of BRCA1 isoforms suggest significant changes in gene expression within tumor types.
Conclusions:
- Dysregulation of BRCA1 alternative splicing is a potential factor in breast and ovarian tumorigenesis.
- These findings suggest a role for alternative splicing in sporadic cancers, independent of germline mutations.